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Abstract
Background: People who opt to participate in scientific studies tend to be healthier,
wealthier and more educated than the broader population. Although selection bias does
not always pose a problem for analysing the relationships between exposures and dis-
eases or other outcomes, it can lead to biased effect size estimates. Biased estimates
may weaken the utility of genetic findings because the goal is often to make inferences in
a new sample (such as in polygenic risk score analysis).
Methods: We used data from UK Biobank, Generation Scotland and Partners Biobank
and conducted phenotypic and genome-wide association analyses on two phenotypes
that reflected mental health data availability: (i) whether participants were contactable by
e-mail for follow-up; and (ii) whether participants responded to follow-up surveys of
mental health.
Results: In UK Biobank, we identified nine genetic loci associated (P<5 10–8) with
e-mail contact and 25 loci associated with mental health survey completion. Both pheno-
types were positively genetically correlated with higher educational attainment and
better health and negatively genetically correlated with psychological distress and
schizophrenia. One single nucleotide polymorphism association replicated along with
the overall direction of effect of all association results.
VC The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
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Conclusions: Re-contact availability and follow-up participation can act as further genetic
filters for data on mental health phenotypes.
Key words: Selection bias, cohort studies, mental health, follow-up studies, genome-wide association study, UK
Biobank, Generation Scotland, Partners Biobank
Introduction
Selection bias in epidemiological and cohort studies occurs
when characteristics of individuals that influence their likeli-
hood of becoming or remaining as study participants are
also related to exposure to risk factors or to outcomes of
interest.1 Selection bias can be introduced at many stages of
a study, including at recruitment, at follow up, during re-
cord linkage or in non-response to questionnaires or tasks
and has the potential to lead to misestimates of phenotypic
and genetic associations.2 For example, a longitudinal study
of psychiatric traits identified several characteristics related
to loss-to-follow-up including: age; education; ancestry; geo-
graphical location; and the presence, severity and comorbid-
ity of anxiety and depression.3 There are several methods
for handling selection bias if and when it needs to be taken
into consideration. When all variables that influence selec-
tion and attrition are known, then bias can potentially be re-
duced or eliminated by conditioning on known variables or
including them as predictors.4 In longitudinal studies, tech-
niques such as inverse probability weighting, where observa-
tions that are similar to those that were lost to follow-up
contribute proportionally more to the analysis, can be used
to correct for selection bias.5 Given the importance of selec-
tion bias on inference, it is crucial to fully characterize it in
any given study population.
Initial ascertainment and re-contact have been demon-
strated to have a genetic basis. For example, individuals
who had a high genetic risk of schizophrenia (calculated
from polygenic risk scores) were less likely to complete
follow-up questionnaires or attend additional data collec-
tion sessions,6 and genetic propensity for other traits have
similar effects.7 Participation in large cohort studies is al-
ready known to have a ‘healthy volunteer’ effect,8 so we
sought to characterize the phenotypic and genetic correlates
of participation in follow-up studies focused on assessing
mental health traits. To this end, we analysed re-contact
and participation in three studies: the Mental Health
Questionnaire (MHQ) online follow-up in UK Biobank9
(N¼ 371 417–373 478), the Stratifying Resilience and
Depression Longitudinally (STRADL) study in Generation
Scotland10 (N¼ 19 994) and the Partners Biobank11
(N¼ 15 925). We conducted phenotypic and genome-wide
association analyses in UK Biobank to determine how par-
ticipants who completed the MHQ differed from the rest of
the sample. We also analysed factors related to whether UK
Biobank participants were contactable by e-mail, as e-mail
invitations were the primary method of recruitment into the
MHQ follow-up. We used participation in the STRADL
questionnaire follow-up in Generation Scotland and a
health information survey follow-up questionnaire in the
Partners Biobank as replication data sets for genetic
findings.
Conducting genetic analyses of selection bias and loss-
to-follow-up can complement and add to existing knowl-
edge gained by comparing biobank cohorts with national
statistics and published disease incidences and by compar-
ing follow-up responders and non-responders on key char-
acteristics. A participant’s decision to continue to engage
in a research study is likely to be multifactorial. Genetic
analyses are a pragmatic first step in indicating what the
many contributing factors are, since genome-wide associa-
tion summary statistics can be efficiently compared with
those from hundreds of other studies.
Genetic analyses can be revealing in other ways. First, ge-
netic and environmental factors may have different magni-
tudes or directions of association with follow-up participation.
Thus, genetic studies of follow-up samples may differ in the
degree to which they are susceptible to selection bias,
Key Messages
• Large cohort studies show a ‘healthy volunteer bias’ and this type of selection bias has a polygenic basis.
• Participants who take part in follow-up studies of mental health differ from participants who do not, and tend to be
healthier, better educated and to have a family history of dementia and/or depression.
• Genetic factors that positively associate with follow-up survey participation are positively related to cognitive function
and psychological well-being and negatively related to psychiatric disorders.
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compared with phenotypic studies. Second, a genetic study
makes it possible to evaluate selection bias from traits that are
only measured in a follow-up sample. For example, the
Mental Health Questionnaire in UK Biobank includes evalua-
tions of depression, anxiety, addiction and trauma that were
not measured at baseline (so it is not possible to directly com-
pare responders and non-responders on these traits).
Comparisons between responders and non-responders can
even be made for traits that are rare or not even measured in
the Biobank. Genetic analyses can be correlated with external
genome-wide summary statistics to elucidate the role of liabil-
ity to disorders that are rare in most biobank samples, such as
anorexia and schizophrenia. Finally, genetic summary statistics
for follow-up response in a large sample in UK Biobank can
become the basis for the analysis of selection bias in other ge-
netic cohorts.
Methods
Samples
UK Biobank (UKB) is a population-based study of health
in middle-aged and older individuals (N¼ 502 616).
Eligible participants were aged 40 to 69 and recruited from
22 assessment centres in the UK. UK Biobank received
ethical approval from the Research Ethics Committee (ref-
erence 11/NW/0382). The present study was conducted
under UK Biobank application 4844.
Generation Scotland: Scottish Family Health Study (GS:
SFHS) is a family-based cohort (N¼ 24 091) recruited
through general practitioners in Scotland.12,13 Eligible par-
ticipants were aged 18 years or older who were able to re-
cruit one or more family members into the study. GS:
SFHS received ethical approval from the Tayside Research
Ethics Committee (reference 05/S1401/89).
Partners Biobank is a hospital-based cohort study from
the Partners HealthCare hospitals with electronic medical
records and genetic data supplemented with electronic
health and lifestyle surveys.11 Recruitment started in 2010
(N¼ 78 726 in 2018) and is ongoing, participating across
several clinics including Brigham and Women’s Hospital
and Massachusetts General Hospital. All participants pro-
vided consent upon enrolment. The current analysis was
restricted to adults aged 18 years or older and of European
ancestry14 with high-quality genotyping data at the time of
analysis.
Re-contact and participation measures
During recruitment and baseline assessment (2006–10),
UKB participants were given the option of supplying an
e-mail address for receiving newsletters and invitations for
online follow-up assessments. Of the 317 785 participants
who supplied an e-mail address, 294 738 provided a usable
one but the remaining 23 047 either provided a syntacti-
cally incorrect or non-existent e-mail address or asked that
their e-mail address be withdrawn. An e-mail address was
not provided by 184 831 UKB participants during baseline
assessment. This variable is called ‘e-mail access’ in the UK
Biobank documentation (field 20005), but we refer to this
phenotype as ‘e-mail contact’. Although additional UK
Biobank participants have subsequently provided an e-mail
address for re-contact, here we analyse the baseline avail-
ability of e-mail contact so that it can be related to other
baseline factors that were captured contemporaneously.
Starting in 2016, UKB participants who had provided
e-mail contact were sent an invitation to an online Mental
Health Questionnaire (MHQ) entitled ‘thoughts and feel-
ings.’9 Participants who had not started the questionnaire
or had only partially completed it were sent reminder
e-mails after 2 weeks and again after 4 months.
Participants also received information about the MHQ in a
postal newsletter with instructions on how to participate.
From data supplied by UK Biobank on 12 June 2018,
157 396 participants had completed the MHQ. Responses
to the MHQ were submitted between July 2016 and July
2017. Mean time between baseline assessment and MHQ
follow-up was 7.5 years (range 5.9–11.2 years). We refer to
this phenotype as ‘MHQ data’.
In 2015, GS: SFHS participants were sent a questionnaire
package by post as part of the Stratifying Resilience and
Depression Longitudinally (STRADL) project, with the aim
of studying psychological resilience.10 Participants were eligi-
ble for follow-up if they had consented to re-contact and if
they had a Community Health Index (CHI) number. Of the
21 525 eligible participants, 9618 responded to the question-
naire, from which we coded a ‘STRADL data’ phenotype.
In the Partners Biobank, following enrolment, partici-
pants were invited to complete the Partners Biobank
Health Information Survey, an optional online lifestyle,
environment and family history survey.14 Of the 15 925
participants of European ancestry with genetic data at the
time of analysis, 6639 responded to the questionnaire.
Phenotype analysis
Demographic and health differences between responders
and non-responders to the STRADL survey have been ana-
lysed previously and showed that, among other differences,
participants who were women, non-smokers or who had
low levels of psychological distress were more likely to re-
spond. We thus first conducted a similar analysis in UK
Biobank. We ran logistic regressions for e-mail contact and
MHQ data using R 3.5.0.15 We examined associations
International Journal of Epidemiology, 2019, Vol. 0, No. 0 3
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with age at initial assessment, sex, geographical region, ed-
ucational qualification, smoking, alcohol consumption,
number of diagnoses in linked electronic health records
and family history of dementia and depression (see
Supplementary Information, available as Supplementary
data at IJE online, for regression input coding).
Genome-wide association, linkage disequilibrium
score analysis, and replication analysis
We conducted genome-wide association studies (GWAS) on
the UKB e-mail contact and MHQ data phenotypes and
conducted gene-based association and gene-set analyses (see
Supplementary Information, available as Supplementary
data at IJE online). We calculated a genomic control factor
(kGC)
16 for each set of GWAS results, which measures the
inflation in test statistics above what would be expected by
chance. Inflation in test statistics can caused both by a large
number of genetic variants having an association with each
trait (polygenicity) and by confounding factors, including
population stratification and relatedness within the sample.
We used linkage disequilibrium (LD) score regression17 to
distinguish polygenicity from confounding. LD score regres-
sion exploits the increase in association test statistics for ge-
netic loci that are closely linked in the region surrounding
each causal genetic variant (indicating polygenicity) to dis-
tinguish from confounding, which is expected to inflate test
statistics evenly across the whole genome. The intercept
from an LD score regression quantifies the test statistic infla-
tion from confounding factors, where an intercept estimate
close to 1.0 indicates no confounding. We also used LD
score regression to estimate the proportion of variance in
these traits attributable to common genetic variants [also re-
ferred to as single nucleotide polymorphism (SNP)
heritability] and calculated genetic correlations with 235
traits using LD Hub. We used false discovery rate to correct
for multiple testing. To test for possible effects of mortality
on loss-to-follow-up, we used the death register to identify
participants whose death occurred before the MHQ assess-
ment (N¼10 623). We then ran a GWAS on MHQ data
with these participants removed.
In the replication data sets (Generation Scotland and
Partners Biobank) we first tested for replication of inde-
pendent SNPs (r2 ¼ 0.1, 250 kb window) after Bonferroni
correction. We calculated the expected power of replica-
tion using the Genetic Association Study power calcula-
tor.18 Following that, we tested for replication of direction
of effect by performing a binomial test for the number of
SNPs with the same direction of effect between the UK
Biobank and Partners association results. We also calcu-
lated LD score genetic correlations17 between the UK
Biobank and Generation Scotland summary statistics, to
estimate genome-wide similarity in phenotypes between
these studies.
Results
Phenotypic associations of e-mail contact and
mental health follow-up (MHQ) data in UK
Biobank
We conducted logistic regressions on e-mail contact (valid
e-mail address provided vs no valid e-mail address pro-
vided) and MHQ participation (those that had completed
the MHQ vs those that had not completed the MHQ) in
UK Biobank, examining the effects of age, sex, geographi-
cal region, educational attainment, alcohol consumption,
smoking status and personal and family history of disease.
We retained participants with complete data for analysis
(N¼ 373 478). Odds ratios from the logistic regressions
are listed in Table 1. Women in UK Biobank were less
likely to have provided an e-mail address but more likely
to take part in the MHQ. There was regional variation in
e-mail contact and MHQ data. Individuals who attended
assessment centres in Greater London and the South West
of England were the most likely to have provided an e-mail
address, whereas individuals from assessment centres in
the North East of England and Scotland were the least
likely. Individuals with greater educational attainment,
those who were not current smokers, those with a fewer
number of hospital diagnoses and those with a family his-
tory of dementia or severe depression were more likely to
have e-mail contact and to have MHQ data.
Genome-wide association analysis of e-mail
contact and MHQ data in UK Biobank
After filtering UK Biobank individuals to a White, British,
unrelated sample, the sample size was N¼ 371 417 for the
GWAS of e-mail contact and N¼ 371 428 for the GWAS of
MHQ data. After clumping, there were nine loci
(P 5 108) for e-mail contact (Figure 1, Table 2;
Supplementary Table S1, available as Supplementary data at
IJE online) and 25 for MHQ participation (Figure 2, Table 3;
Supplementary Table S11, available as Supplementary data at
IJE online). The kGC was 1.29 for e-mail contact and 1.37 for
MHQ data. The LD score intercept for e-mail contact and for
MHQ data in UK Biobank was 1.013 [standard error (SE)
0.008] and 1.020 (SE 0.008). respectively. This yielded infla-
tion ratios indicating that only 3.7% (SE 0.025) and 4.3%
(SE 0.020) of the inflation in test statistics for e-mail contact
and MHQ data was caused by confounding factors, and thus
most of the inflation in test statistics was attributed to a large
number of genetic loci influencing both traits (polygenicity).
4 International Journal of Epidemiology, 2019, Vol. 0, No. 0
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Loci discovery and annotation of the e-mail
contact and MHQ phenotypes
The nine loci associated with e-mail contact were found to
contain an over-representation of SNPs found in ncRNA
intronic regions (57.5%), as well as SNPs found in intronic
regions (28.4%) (Supplementary Figure S1 and Supplementary
Table S1, available as Supplementary data at IJE online).
Evidence was also found that these loci contained regula-
tory regions of the genome, indicated by 32.0% of the
SNPs in the genomic loci having RegulomeDB (RDB) less
Table 1. Logistic regression on e-mail contact and MHQ data in UK Biobank (N¼373 478). Regression coefficients are expressed
as odds ratios for increased probability of having e-mail contact and increased probability of having MHQ data
E-mail contact MHQ data
Variable N OR (SE) 95% CI OR (SE) 95% CI
Age (SD) 373 478 0.85 (0.004) 0.846–0.861 1.01 (0.004) 0.998–1.014
Sex Female 211 768 1  1 
Male 161 710 1.11 (0.010) 1.093–1.131 0.90 (0.008) 0.883–0.914
Region East Midlands 25 307 1  1 
Greater London 50 795 1.85 (0.032) 1.785–1.909 1.13 (0.022) 1.088–1.173
North East 27 594 0.49 (0.008) 0.470–0.501 0.87 (0.018) 0.835–0.904
North West 54 053 0.81 (0.013) 0.781–0.833 0.84 (0.012) 0.817–0.866
Scotland 27 557 0.42 (0.009) 0.405–0.439 0.83 (0.017) 0.800–0.866
South East 34 114 0.84 (0.016) 0.805–0.867 1.13 (0.020) 1.088–1.165
South West 33 410 1.13 (0.021) 1.087–1.171 1.08 (0.020) 1.042–1.121
Wales 15 741 0.58 (0.013) 0.558–0.611 0.83 (0.020) 0.796–0.873
West Midlands 33 042 0.63 (0.011) 0.606–0.649 0.83 (0.016) 0.799–0.862
Yorkshire 71 865 1.00 (0.016) 0.967–1.028 0.93 (0.014) 0.900–0.957
Qualifications None 53 654 1  1 
GCSE 124 377 2.35 (0.028) 2.297–2.408 2.29 (0.029) 2.230–2.342
A Levels 44 132 3.43 (0.048) 3.338–3.525 3.53 (0.057) 3.421–3.642
Other 19 583 2.53 (0.042) 2.451–2.616 2.72 (0.052) 2.620–2.823
College/university 131 732 4.27 (0.054) 4.163–4.375 4.43 (0.056) 4.322–4.541
Smoking Never 210 858 1  1 
Previous 126 802 1.13 (0.009) 1.116–1.152 1.06 (0.008) 1.042–1.074
Current 35 818 0.71 (0.009) 0.689–0.723 0.73 (0.010) 0.706–0.744
Alcohol Units/week (SD) 373 478 1.05 (0.004) 1.038–1.053 1.03 (0.005) 1.021–1.039
Anthropometry Body mass index (SD) 373 478 0.95 (0.004) 0.940–0.953 0.88 (0.004) 0.877–0.893
Diagnoses, yes (vs no)
Mental disorder 24 668 0.75 (0.011) 0.729–0.774 0.68 (0.012) 0.654–0.701
Injury 59 706 0.90 (0.007) 0.881–0.909 0.83 (0.009) 0.815–0.851
Other disease 278 019 0.95 (0.009) 0.929–0.963 0.91 (0.009) 0.889–0.923
Family history, yes (vs no)
Alzheimer’s/dementia 52 238 1.18 (0.013) 1.157–1.208 1.22 (0.013) 1.198–1.250
Severe depression 54 651 1.04 (0.011) 1.022–1.066 1.11 (0.012) 1.084–1.131
Figure 1.Manhattan plot of e-mail contact in UK Biobank.
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than 2, indicating that genetic variation in these loci is
likely to affect gene expression. Finally, 77.6% of the SNPs
within the independent genomic loci had a minimum chro-
matin state of <8. This is further evidence that these loci
are located in an open chromatin state and that they are lo-
cated within regulatory regions. Using the GWAS cata-
logue, lead and tagging SNPs from these nine independent
genomic loci were found to overlap with loci previously as-
sociated with body mass index and obesity (two loci), as
well as with educational attainment and intelligence (three
loci) (Supplementary Table S2, available as Supplementary
data at IJE online).
The 25 loci associated with the MHQ participation phe-
notype notably included rs429358, a missense mutation in
APOE. The rs429358-C allele is a marker for APOE- e4
genotype, and the direction of the effect for this SNP indi-
cated that participants with more copies of APOE-e4 were
less likely to participate in the MHQ [odds ratio (OR) ¼
0.9426 0.0057SE for each additional e4 copy]. Functional
annotation of the SNPs found within these regions showed
that these SNPs were primarily located in introns (47.3%),
and intergenic regions (17.7%) and 2.9% had no known
function (Supplementary Figure S2 and Supplementary
Table S8, available as Supplementary data at IJE online).
Of these SNPs, 30.8% had an RDB score of less than 2 and
83.8% had a minimum chromatin value of less than 8, pro-
viding further evidence that these variants are located in
regions of the genome that are linked to gene regulation.
These 25 loci showed overlap with the loci identified in
previous GWAS examining cognitive abilities and educa-
tion (six loci), schizophrenia (five loci), and Alzheimer’s
disease (one locus) (Supplementary Table S9, available as
Supplementary data at IJE online).
Gene mapping of the e-mail access and MHQ
phenotype
We used three strategies for mapping the SNPs in the associ-
ated loci to genes. First, positional mapping aligned the
SNPs from the independent genomic loci associated with e-
mail contact to 20 genes by using location, whereas eQTL
mapping matched cis-eQTL SNPs to 40 genes whose level
of expression they have been shown to influence. Finally,
chromatin interaction mapping annotated SNPs to a total of
41 genes, using three-dimensional DNA-DNA interactions
between the SNPs’ genomic regions, and close or distant
genes (Supplementary Tables S4 and S5, Supplementary
Figure 5a–f, available as Supplementary data at IJE online).
Figure 2.Manhattan plot of data available in MHQ follow-up.
Table 2. Top lead SNPs associated with e-mail contact in UK Biobank. Direction of effects are listed for the UK Biobank discovery
sample and the Generation Scotland and Partners Biobank replication samples as either positive (þ) or negative ()
Chr SNP Location (bp) A1/A2 Freq. OR (SE) P-value Direction
1 rs632180 234, 758, 181 T/C 0.70 0.973 (0.005) 2.0  108 þ
2 rs7597665 34, 420, 702 C/T 0.29 1.031 (0.005) 1.1  109 þþþ
2 rs1455343 199, 519, 691 T/G 0.38 0.974 (0.005) 2.2  108 þ
3 rs73078357 48, 695, 834 C/T 0.12 1.038 (0.007) 4.5  108 þþþ
3 rs111488606 49, 864, 924 CA/C 0.44 0.973 (0.005) 2.3  108 
5 rs6452788 87, 712, 913 A/G 0.24 1.032 (0.005) 2.9  109 þþ
5 rs4976602 167, 843, 998 A/G 0.11 0.96 (0.007) 2.7  108 
6 rs1487441 98, 553, 894 A/G 0.49 1.031 (0.005) 9.5  1012 þþþ
18 rs1788784 21, 159, 630 G/A 0.66 1.031 (0.005) 1.3  1010 þþþ
A1, effect allele; A2, non-effect allele; Chr, chromosome; Freq., frequency of effect allele; OR, odds ratio; SE, standard error.
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Collectively these mapping strategies identified 70 unique
genes, of which 21 were implicated by two mapping strate-
gies and 10 were implicated by all three. A total of five
genes, TNNI3K, LRRIQ3, NEGR1, FPGT and FPGT-
TNNI3K, were implicated using all three methods and
showed evidence of a chromatin interaction between two in-
dependent genomic risk loci (Supplementary Table S4,
available as Supplementary data at IJE online). Gene-based
statistics derived in MAGMA indicated a role for 72 genes
(Supplementary Table S5, available as Supplementary data
at IJE online), four of which overlapped with genes impli-
cated by all three mapping strategies (Supplementary Figure
S3, available as Supplementary data at IJE online).
For the MHQ data phenotype, positional mapping impli-
cated 42 genes, with eQTL mapping indicating a role for 86
genes. Chromatin interaction mapping annotated a total of
124 genes (Supplementary Tables S14 and S15, Supplementary
Figure S6a–m, available as Supplementary data at IJE online).
Across these three mapping strategies, 181 unique genes were
identified, with 46 of these being implicated by two mapping
strategies and 25 being implicated by all three. MAGMA was
also used and indicated a role for 81 genes (Supplementary
Figure S4 and Supplementary Table S15, available as
Supplementary data at IJE online). Fifteen of these 81
genes overlapped with those identified using the three map-
ping strategies.
Gene-set and gene property analysis
The presynaptic membrane gene-set was enriched for the e-
mail contact phenotype (P¼5.19 107) (Supplementary
Table S6, available as Supplementary data at IJE online).
Gene property analysis showed a relationship between expres-
sion in the Epstein-Barr virus (EBV)-transformed lymphocyte
cells (P¼ 9.24 104) and for gene expression in the early
mid-prenatal time of life (P¼ 0.004) (Supplementary Tables
S9 and S10, available as Supplementary data at IJE online).
For the MHQ data phenotype none of the gene sets were
enriched (Supplementary Table S16, available as
Supplementary data at IJE online). However, gene property
analysis indicated a relationship between gene expression in
the brain and the MHQ phenotype (P¼ 2.64 104)
(Supplementary Table S17, available as Supplementary data
at IJE online). When examining the specific tissue gene
groupings, this relationship was driven by expression
change in the cerebellar hemisphere (P¼ 8.52 106) and
Table 3. Top lead SNPs associated with MHQ data. Direction of effects are listed for the UK Biobank discovery sample and the
Generation Scotland and Partners Biobank replication samples as either positive (þ) or negative ()
Chr SNP Location (bp) A1/A2 Freq. OR (SE) P-value Direction
1 rs7542974 72, 544, 704 A/G 0.25 1.032 (0.006) 3.8  108 þþþ
1 rs485929 74, 678, 285 G/A 0.39 1.028 (0.005) 3.7  108 þþ
1 rs532246 84, 411, 238 G/A 0.74 0.968 (0.005) 7.0  109 þ
1 rs2789111 243, 346, 404 C/T 0.38 0.968 (0.005) 1.5  1010 þ
2 rs35028061 49, 479, 987 GT/G 0.38 1.029 (0.005) 1.9  108 þ
3 rs9917656 48, 581, 513 C/T 0.30 1.03 (0.006) 3.2  108 þþ
3 rs13082026 52, 962, 681 T/C 0.44 0.972 (0.005) 2.4  108 þ
4 rs57692580 106, 214, 476 A/T 0.39 0.973 (0.005) 2.8  108 þþ
5 rs34635 60, 513, 501 G/A 0.42 0.972 (0.005) 1.2  108 
5 rs146681214 133, 867, 867 AC/A 0.18 1.039 (0.007) 3.6  109 þþþ
5 rs2336897 167, 050, 276 T/C 0.69 1.031 (0.005) 5.2  109 þþ
6 rs3993747 31, 580, 507 G/A 0.35 0.969 (0.005) 9.5  1010 
6 rs59732267 98, 432, 302 CA/C 0.52 0.972 (0.005) 2.5  108 
8 rs28716319 83, 269, 854 G/A 0.28 1.031 (0.005) 2.7  108 þþ
8 rs13262595 143, 316, 970 G/A 0.56 1.03 (0.005) 1.0  109 þþþ
9 rs6474966 15, 757, 537 A/G 0.46 1.028 (0.005) 2.8  108 þþþ
9 rs11793831 23, 362, 311 T/G 0.42 1.027 (0.005) 4.3  108 þþ
11 rs1984389 31, 740, 989 C/A 0.54 0.973 (0.005) 2.4  108 
11 rs10791143 131, 278, 676 G/A 0.62 1.034 (0.005) 1.5  1011 þþþ
16 rs4616299 7, 657, 432 G/A 0.40 0.972 (0.005) 1.2  108 
17 rs56058331 56, 427, 128 A/G 0.42 1.029 (0.005) 1.0  108 þþþ
18 rs1261078 52, 866, 791 G/A 0.05 0.927 (0.010) 5.6  1012 þ
19 rs34232444 4, 965, 404 C/T 0.35 1.029 (0.005) 2.5  108 þþ
19 rs3746187 18, 279, 816 G/A 0.40 0.968 (0.005) 9.8  1011 
19 rs429358 45, 411, 941 C/T 0.15 0.942 (0.006) 4.6  1019 
A1, effect allele; A2, non-effect allele; Chr, chromosome; Freq., frequency of effect allele; OR, odds ratio; SE, standard error.
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the cerebellum (P¼1.27 105) (Supplementary Table
S18, available as Supplementary data at IJE online). A rela-
tionship between gene expression in the early prenatal life-
span (P¼ 0.002) and the early mid-prenatal lifespan was
also found (P¼ 5.33104) (Supplementary Table S19,
available as Supplementary data at IJE online).
LD score regression analysis
We used LD score regression to estimate SNP heritability
from the GWAS results. Heritability on the liability scale for
e-mail contact was 0.073 (0.004 SE) and for MHQ data
was 0.099 (0.004 SE). The genetic correlation between
e-mail contact and MHQ data was 0.822 (0.020 SE).
We used LD Hub19 to estimate genetic correlations
with a large number of other traits. Both e-mail contact
and having MHQ data were genetically correlated with a
broad spectrum of traits. Results for an illustrative set of
traits are plotted in Figure 3 and the results for all traits are
listed in Supplementary Table S21, available as
Supplementary data at IJE online. For most anthropomet-
ric, behavioural, cognitive, psychiatric, health-related and
life history traits the direction of the genetic correlations
with e-mail contact and MHQ participation was the same.
In general, genetic factors associated with providing an
e-mail address for re-contact to UK Biobank and taking
part in the MHQ were also associated with better health,
higher intelligence, lower burden of psychiatric disorders
and a slower life-history (e.g. later age at menarche, age at
first birth and age at menopause). Both e-mail contact and
MHQ participation were not genetically correlated with
any traits categorized as bone, kidney, uric acid and metals
(transferrin/ferritin). Additionally, e-mail contact was not
genetically correlated with glycaemic traits and MHQ data
availability was not genetically correlated with hormone or
metabolite phenotypes.
Effect of mortality on MHQ genetic associations
To test for the role of mortality on our findings, we re-ran
the genome-wide association analysis of MHQ data avail-
ability after removing participants whose dates of death
occurred before the MHQ assessment. The overall infla-
tion in association test statistics including and excluding
deceased participants was identical (mean v2 ¼ 1.438) and
the genetic correlation between the two sets of summary
statistics was 0.9996 (SE ¼ 0.0002). We compared the top
independent associated SNPs in the GWAS in the larger
sample with those that excluded deaths (Supplementary
Table S24 and Figure S7, available as Supplementary data
at IJE online). Although there were three SNPs that no lon-
ger passed the criterion for genome-wide significance, there
was no appreciable change in the effect sizes estimates for
any of the SNPs
Replication in generation Scotland and partners
Biobank
We examined whether any of the associations results for
the e-mail and MHQ data phenotypes replicated in an in-
dependent sample, using whether members of Generation
Scotland participated in the STRADL follow-up of mental
health. At an alpha criterion of 0.05/34 and an average ge-
notype relative risk of 1.015, there was 4% power to repli-
cate in Generation Scotland and 2% power in Partners
Biobank, and replicating the UK Biobank findings requires
approximately 200 000 cases and controls to achieve 90%
power.18 None of the independent SNPs in the UKB
GWASs replicated in Generation Scotland after Bonferroni
correction (34 tests) (Supplementary Tables S22 and S23,
available as Supplementary data at IJE online). We ob-
served replication evidence for one independent SNP
(rs9917656, 6.2 10–4) in Partners Biobank after
Bonferroni correction (Supplementary Tables S22 and S23,
available as Supplementary data at IJE online). Between
UK Biobank and Partners Biobank, more of the SNPs for
survey participation had the same direction of effect than
expected (20/25, exact binomial test P-value ¼ 0.002).
Furthermore, the STRADL data phenotype was moder-
ately genetically correlated with both UKB e-mail contact
(rg ¼ 0.430, SE ¼ 0.112, P¼ 0.0001) and UKB MHQ data
(rg ¼ 0.619, SE ¼ 0.130, P¼ 1.98 10–6) and had an SNP
heritability on the liability scale of 0.112 (SE 0.0408).
Discussion
Using data from UK Biobank, we found that individuals
who provided an e-mail address for re-contact and who
participated in follow-up surveys of mental health differed
from those who did not with regards to demographic, psy-
chological, health, lifestyle and genetic factors. The UK
Biobank sample differs from the UK population,20 and our
results show that ascertainment processes also exert an ef-
fect on follow up assessments. Most of the phenotypic and
genetic associations were in the same direction. These
results were not due to population stratification, as only
4% of the inflation in GWAS statistics could be attributed
to factors other than polygenic heritability. Having greater
educational attainment, being a non-smoker or a former
smoker, having fewer hospital diagnoses of illness or injury
and having a family history of dementia or a family history
of serious depression all predicted greater likelihood of
providing e-mail contact information. Furthermore, those
variables were also associated with providing responses to
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the online Mental Health Questionnaire (MHQ).
Importantly for understanding the composition of the
MHQ subset, having an inpatient diagnosis of a mental
disorder was associated with lower participation rates in
the MHQ [OR ¼ 0.68, 95% confidence interval (CI) ¼
0.65-0.70], and this was a larger effect size than other
hospital diagnoses, specifically injury (OR ¼ 0.83) and
non-psychiatric disorders (OR ¼ 0.91). A few effects went
in the opposite direction between the e-mail contact and
MHQ data variables, with men and younger individuals
more likely to provide an e-mail address to UK Biobank,
whereas women were more likely to provide MHQ data.
E-mail contact and MHQ data availability had SNP
heritabilities of 7.3% and 9.9%, respectively. We
Figure 3. LD score genetic correlations (rg) with e-mail contact (triangle) and MHQ data (circle), with 95% confidence intervals.
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identified nine independent SNPs associated with e-mail
contact and 25 for MHQ data, more than for many GWAS
studies of disease traits in the same sample. Loci for both
phenotypes were mostly located within regulatory regions.
Of particular interest was the association of MHQ data
availability with the apolipoprotein E (APOE) e4 genotype
that is a major risk factor for Alzheimer’s disease.21 One
SNP associated with MHQ data replicated in the Partners
Biobank sample. The SNP, rs9917656, is in an intron in
the 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase
4 (PFKFB4), a signally enzyme involved in switching be-
tween different forms of carbohydrate metabolism.22
However, several other genes are implicated in this locus
by positional mapping (genomic locus 6 in Supplementary
Table S13, available as Supplementary data at IJE online).
Given the effect sizes found in the discovery sample, both
Generation Scotland and Partners were underpowered for
replicating association results. However, the consistent
directions of effect in the Partners cohort and the strong ge-
netic correlation between STRADL participation and the
e-mail contact and MHQ data phenotypes, suggest that
similar genetic factors are driving participation in follow-
up studies.
E-mail contact and MHQ data shared similar genetic
correlations with other traits. There were strong genetic
correlations between e-mail contact and indicators of cog-
nitive ability (college completion, rg ¼ 0.76; intelligence,
rg ¼ 0.73). Contact and data availability were also geneti-
cally associated with a lower burden of genetic risk for
mental illness and lower BMI. These results were in the
same direction as the phenotypic analysis. The negative ge-
netic correlation with schizophrenia matches results from
follow-up participation in the ALSPAC cohort using poly-
genic risk scores,6 and suggests that this association is not
specific to schizophrenia.
The similarity in the results for phenotypic and genetic
factors associated with e-mail contact and MHQ data
shows that the availability of an individual to be contacted
by e-mail, and their choice to participate, both act as a fil-
ter for selection into the subsample of UK Biobank with
Mental Health Questionnaire data. Notably, self-reports
of a family history of dementia and a family history of se-
vere depression were more common in e-mail providers
and MHQ completers, but individual genetic associations
with both these disorders showed negative correlations.
Individuals who reported dementia or severe depression in
their family were therefore more likely to be MHQ partici-
pants, even though having a personal genetic predisposi-
tion to these disorders may also decrease their likelihood
of participating. Knowledge of family history may be a
strong motivational factor for participating in follow-up
surveys of mental health.
Our sample was large enough that we were able to iden-
tify specific genetic loci that were related to participation in
follow-up studies of mental health. We were also able to ana-
lyse the genetics of one particular factor (the availability of e-
mail contact for receiving invitations) that is heavily involved
in the specific process of follow-up participation. However, a
limitation of our analysis is that information on e-mail con-
tact was available for participants at baseline only, and thus
did not distinguish the entire subset of participants who
would have received an e-mail invitation. Another limitation
is that information from electronic health records only cov-
ered hospital admissions and thus would underestimate asso-
ciations with milder health conditions. Our study also does
not address factors that would differentially influence partici-
pation of individuals of non-European ancestry.
Individuals in large epidemiological cohorts who partici-
pate in follow-up surveys differ in their patterns of pheno-
typic and genetic association with traits of interest from
those who do not. Because most factors had a consistent re-
lationship with the two-step selection process (contactability
by e-mail and opting to participate in follow-up), it is likely
that these same factors may also differentiate people who
choose to become part of the cohort in the first place from
other people in the larger population. These factors are very
likely to bias the selection of individuals for inclusion in
population-based studies towards those with positive family
histories but lower personal genetic risk of mental health
conditions such as depression and dementia. Analysing vari-
ables within a follow-up study may have the effect inducing
statistical dependence or attenuating estimates of the rela-
tionships among variables.2 Figure 4a illustrates a
hypothesized causal model where a polygenic risk score
(PRS) influences a phenotype or outcome Y via an interme-
diate phenotype X. This model could be tested by d-separa-
tion23: if the model is true, then regressing Y on X will result
in conditional independence of PRS and Y. Figure 4b illus-
trates a scenario analysing the effect of the PRS where par-
ticipation in follow-up is a collider for the two phenotypes
when they do not have a causal relationship with each
other. Analysing data only within the follow-up sample cre-
ates non-independence between the X and Y traits and thus
between PRS and Y. Even when one trait causes the other,
conditioning on follow-up participation can bias the esti-
mate of PRS on the downstream trait (Figure 4c). A scenario
where only one of the traits causes follow-up would not re-
sult in biased estimates of the effects of PRS (Figure 4d).
Going forward, studies should evaluate (e.g. using simu-
lations2) the particular effects that selection and attrition
might have on effect estimates and, where available, check
results from follow-up assessments against those from base-
line data, even in the cases where the follow-up data provide
better or more comprehensive measures of phenotypes of
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interest. Because continued participation in large cohorts
studies recapitulates the ‘healthy volunteer’ effect, compar-
ing responders and non-responders in follow-up surveys
may be a useful way to analyse how selection bias may in-
fluence the generalizability and accuracy of findings.
Data availability
GWAS summary statistics for the UK Biobank e-mail con-
tact and Mental Health Questionnaire data are available
from [https://doi.org/10.7488/ds/2554]. Underlying study
data are available to bona fide researchers from UK
Biobank [https://www.ukbiobank.ac.uk/], Generation
Scotland [http://www.generationscotland.org/] and
Partners HealthCare Biobank [https://biobank.partners.
org].
Supplementary Data
Supplementary data are available at IJE online.
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